Dexcom COVID-19 Assistance program in US

Announced today.

When the program launches for current customers who meet eligibility requirements, Dexcom will:

  • Enroll eligible customers in the program during the COVID-19 pandemic
  • Provide two 90-day supply shipments of Dexcom CGM system supplies, with each shipment including one transmitter and three boxes of three sensors
  • Reduce customer cost to $45 per 90-day supply shipment

The Dexcom COVID-19 patient assistance program will be available to current U.S. customers who have lost insurance coverage as a result of the COVID-19 pandemic. Customers that are eligible for coverage of their Dexcom CGM systems under a federal or state government program (such as Medicare, Medicaid or VA benefits) are not eligible to participate in this program. The program will launch in the next several weeks and will be available during the COVID-19 pandemic in the United States only.


This is what the cost should be all the time.